This research demonstrates a novel nanoplatform enhancing tumor treatment via dual-light activation, suggesting improved therapeutic outcomes.
Photodynamic Therapy This cover illustrates a lipid-hybridized nanoplatform (CSA-psICG/BdTT-BNBE) for cascade-activated photodynamic therapy. Guided by CSA–CD44 targeting, the system responds to dual-light irradiation (NIR and white light), triggering glutathione depletion and amplified ROS generation. This strategy enables spatiotemporally controlled activation and enhances therapeutic efficacy against tumors. More in the Research Article (e12546), Jeeyeon Lee, Jae-Young Lee, and co-workers.
No takes yet. Share an insight, caveat, or question.
Yoo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: